#FGBlog: Dedicated Barrett’s oesophagus surveillance lists: the future for better dysplasia detection?

Getting surveillance for Barrett’s oesophagus (BO) right is critical for early detection and prevention of oesophageal adenocarcinoma. When identified early, Barrett’s can be treated effectively with minimally invasive endoscopic techniques. Despite clear national guidelines on when and how to perform surveillance for BO, adherence to these guidelines is variable. In the most recent edition of […]

Read More…

#FGBlog: New colonoscopy training pathway and certification: will we rise to the challenge?

  Colonoscopy is the gold standard technique to assess the lower gastrointestinal tract, allowing direct visualisation of the bowel mucosa, targeted biopsy, and appropriate therapy including resection of precancerous lesions. Although the quality of colonoscopy has improved, there is a still wide variation in quality of colonoscopies performed in the United Kingdom (UK).1, 2 With […]

Read More…

A new approach to coeliac disease diagnosis?

It is well-established that UK endoscopy services are under pressure, with post-Covid waiting lists pushing demand to an all-time high.1 Whilst a no-biopsy approach has been advocated in the diagnosis of coeliac disease (CD) in children since 2012, British Society of Gastroenterology (BSG) guidelines issued in 2014 still advise four duodenal biopsies for the diagnosis […]

Read More…

#FGBlog :Disparity between current guidelines and prescribing in IBD: Is it a lack of awareness or lack of convincing evidence?

It is a well-known fact that the greatest limitation of large randomised controlled trial studies is their lack of external validity with specific patients being excluded from important studies due to their co-morbidities including surgical history (such as ileostomies), age (whether that be children or the elderly) and gender (with females being more likely to […]

Read More…

A potential new role for faecal calprotectin in monitoring biliary tract disease

Most gastroenterologists have long been familiar with faecal calprotectin (fCal), and it is widely used as a non-invasive test both to screen for the presence of inflammation in those with lower GI symptoms, and to quantitatively monitor disease activity in inflammatory bowel disease (IBD) patients. Calprotectin is a member of the S100 protein family found […]

Read More…

#FGCup

Despite the ongoing COVID0-19 pandemic, the last year has seen Frontline Gastroenterology continue to publish great content that educates and informs doctors around the world to provide care for their patients. We are grateful to everyone who has submitted their work to us. To celebrate this, we have launched the #FGCup on Twitter to allow […]

Read More…